SIGA Technologies, Inc. (NASDAQ:SIGA) Q4 2023 Earnings Conference Call March 12, 2024 4:30 PM ET
Company Participants
Diem Nguyen - Chief Executive Officer
Daniel Luckshire - Executive Vice President and Chief Financial Officer
Conference Call Participants
Soo Romanoff - Edison Group
Lance Kimbrough - Ivy Creek Capital
Operator
Welcome to the SIGA Business Update Call. Before we turn the call over to SIGA management, please note that any forward-looking statements made during this call are based on management's current expectations and observations and are subject to risks and uncertainties, that could cause actual results to differ from the forward-looking statements.
SIGA does not undertake any obligation to update publicly any forward-looking statements to reflect events or changed circumstances after this call. For a discussion of factors that could cause results to differ, please see the company's filings with the Securities and Exchange Commission, including, without limitation, the company's annual report on Form 10-K, for the year ended December 31, 2023. And its subsequent reports on Form 10-Q and Form 8-K.
I will now hand the call over to Diem Nguyen, CEO of SIGA. Please go ahead.
Diem Nguyen
Good afternoon, everyone, and thank you for joining today's call and review of our business results for the fourth quarter and full-year of 2023. I am joined by Dan Luckshire, our Chief Financial Officer; and we're pleased to have this opportunity to provide an update to our shareholders. After the update, we'll be happy to answer any other questions.
I'd like to begin by recognizing the work and contributions of Phil Gomez, who served as SIGA's CEO for the seven years. Phil was instrumental in transforming our company into a more commercial organization, with sales in over 25 countries and securing key regulatory approvals for our TPOXX franchise. On behalf of our team, I want to thank Phil for his many contributions to making SIGA the strong company it is today.
On a personal note, I'm excited to join SIGA and take on the role of CEO. Having spent nearly three decades focused on addressing unmet needs in health care, I look forward to building on SIGA's success and driving greater growth for the benefit of our patients, customers and shareholders. I have a deep-seated passion for scientific advancement and innovation, as well as an extensive experience leading successful multibillion-dollar commercial organization. I'm extremely excited to leverage this experience to help fulfill SIGA's potential and have our essential therapies available worldwide.